Ending last week, the Drug Enforcement Administration (DEA) finally reversed its project to criminalize 5 new psychedelic substances, as first reported by Microdose.
Had the agency decided to advance with the proposal, the five tryptamines (4-OH-DiPT, 5-MeO-AMT, 5-MeO-MiPT, 5-MeO-DET and DiPT) would have been moved to Schedule 1 of the Controlled Substances Act, a category reserved for substances considered to behold high potential for abuse and therefore no accepted medical use.
Public comments at the DEA’s public hearing in January and February and additional others following it seem to have enacted enough pressure on the agency, as it has withdrawn its project before the scheduled hearing in August.
A reduced group composed by therapeutic psychedelics companies, experts and attorneys are responsible for the proposal’s withdrawal and for what will most likely be the agency’s next step: a request to the HHS for a further evaluation of the five tryptamines, and a consequent reconsideration on whether or how to schedule them afterwards.
Read the lead advocates’ comments on the recent decision below.
5 psychedelic tryptamines, kept off schedule I?
— Graham Pechenik (@calyxlaw) July 22, 2022
DEA scheduling proceedings—terminated:
“DEA is withdrawing the proposed rule…canceling the public hearing & terminating the pending hearing proceedings”
Unprecedented outcome—a result of extraordinary lawyering by Matt Zorn
1/2 https://t.co/ZfBq8OJurB pic.twitter.com/OJHjhcDNil
Congratulations to challengers @TactogenInc & @MindstateDesign
— Graham Pechenik (@calyxlaw) July 22, 2022
With huge thanks also to expert statements from @AndrewChadeayne & @ProfDavidNutt
I’m grateful to serve as co-counsel w Matt, as science & common sense carry the day
Government notice: https://t.co/y79zLcaby0
2/2
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
BENZINGA CANNABIS CAPITAL CONFERENCE & AWARDS
The Benzinga Cannabis Awards are coming back to the September 27-28, 2023 Cannabis Capital Conference to celebrate the NEW, CREATIVE, INNOVATIVE, and OUTSTANDING companies of the cannabis industry.
- Earn global recognition for your achievements.
- Shine a spotlight on the people around you that deserve their moment.
- Celebrate with the newest, hottest and most successful in the cannabis industry.
Nominate or apply NOW and help us celebrate the people, solutions, and companies leading the way in cannabis!
Join us on September 27-28, 2023 at Chicago Marriott Downtown Magnificent Mile in Chicago, IL.